MedDataX Logo

UK CARDIOvascular Immune-Mediated Inflammatory Diseases (CARDIO-IMID) Registry Study

NCT06478277 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2026-02-06

No results posted yet for this study

Summary

The goal of this observational study is to develop a large, deeply characterised cohort that will be a platform for collaborative clinical and translational research into cardiovascular (CV) disease (CVD) and Immune-mediated-inflammatory-diseases (IMID). The main aim is to evaluate whether existing blood cardiac biomarkers predict adverse cardiovascular outcomes. The study will capture standard of care CV and associated health data (clinical, biochemistry/pathology and investigations) in patients across the IMIDs. Optional biological and/or imaging sub-studies will provide additional data and/or samples for associated analyses.

Conditions

  • Cardiovascular Diseases
  • Immune-Mediated Inflammatory Diseases

Sponsors & Collaborators

  • University of Cambridge

    collaborator OTHER

  • University of Oxford

    collaborator OTHER

  • University of Edinburgh

    collaborator OTHER

  • University of Leeds

    collaborator OTHER

  • Imperial College London

    collaborator OTHER

  • Medical Research Council

    collaborator OTHER_GOV

  • British Heart Foundation

    collaborator OTHER

  • Swansea University

    collaborator OTHER

  • British Heart Foundation Data Science Centre

    collaborator UNKNOWN

  • University of Manchester

    lead OTHER

Principal Investigators

  • Maya H Buch, MD · University of Manchester

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-02-04
Primary Completion
2028-08-31
Completion
2028-08-31

Countries

  • United Kingdom

Study Locations

Related Clinical Trials

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06478277 on ClinicalTrials.gov